Literature DB >> 25699229

Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

Cecilia Söderberg-Nauclér1, John Inge Johnsen1.   

Abstract

During the last years increasing evidence implies that human cytomegalovirus (CMV) can be attributed to human malignancies arising from numerous tissues. In this perspective, we will review and discuss the potential mechanisms through which CMV infection may contribute to brain tumors by affecting tumor cell initiation, progression and metastasis formation. Recent evidence also suggests that anti-CMV treatment results in impaired tumor growth of CMV positive xenografts in animal models and potentially increased survival in CMV positive glioblastoma patients. Based on these observations and the high tumor promoting capacity of this virus, the classical and novel antiviral therapies against CMV should be revisited as they may represent a great promise for halting tumor progression and lower cancer deaths.

Entities:  

Keywords:  Brain tumor; Cytomegalovirus; Glioblastoma; Medulloblastoma; Oncovirus

Year:  2015        PMID: 25699229      PMCID: PMC4308527          DOI: 10.5493/wjem.v5.i1.1

Source DB:  PubMed          Journal:  World J Exp Med        ISSN: 2220-315X


  119 in total

1.  Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Authors:  Alexia Ghazi; Aidin Ashoori; Patrick J Hanley; Vita S Brawley; Donald R Shaffer; Yvonne Kew; Suzanne Z Powell; Robert Grossman; Zakaria Grada; Michael E Scheurer; Meenakshi Hegde; Ann M Leen; Catherine M Bollard; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk; Nabil Ahmed
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

Review 2.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis.

Authors:  Erik Slinger; David Maussang; Andreas Schreiber; Marco Siderius; Afsar Rahbar; Alberto Fraile-Ramos; Sergio A Lira; Cecilia Söderberg-Nauclér; Martine J Smit
Journal:  Sci Signal       Date:  2010-08-03       Impact factor: 8.192

4.  Medulloblastoma: a disease with disorganized developmental signaling cascades.

Authors:  Ninib Baryawno; Baldur Sveinbjörnsson; Per Kogner; John Inge Johnsen
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 5.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

6.  Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells.

Authors:  E Speir; Z X Yu; V J Ferrans; E S Huang; S E Epstein
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

7.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

Review 8.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 9.  Cell- and peptide-based immunotherapeutic approaches for glioma.

Authors:  Ryuya Yamanaka
Journal:  Trends Mol Med       Date:  2008-04-09       Impact factor: 11.951

10.  Detection of human cytomegalovirus in normal and neoplastic breast epithelium.

Authors:  Lualhati E Harkins; Lisa A Matlaf; Liliana Soroceanu; Katrin Klemm; William J Britt; Wenquan Wang; Kirby I Bland; Charles S Cobbs
Journal:  Herpesviridae       Date:  2010-12-23
View more
  20 in total

Review 1.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

Review 2.  Vaccination strategies for neuro-oncology.

Authors:  John H Sampson; Duane A Mitchell
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 3.  The Safety of available immunotherapy for the treatment of glioblastoma.

Authors:  S Harrison Farber; Aladine A Elsamadicy; Ahmet Fatih Atik; Carter M Suryadevara; Pakawat Chongsathidkiet; Peter E Fecci; John H Sampson
Journal:  Expert Opin Drug Saf       Date:  2017-01-03       Impact factor: 4.250

4.  Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms.

Authors:  Elizabeth C Delery; Andrew G MacLean
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

5.  Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines.

Authors:  Travis S Johnson; Zachary B Abrams; Xiaokui Mo; Yan Zhang; Kun Huang
Journal:  J Neurovirol       Date:  2017-07-10       Impact factor: 2.643

6.  Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas.

Authors:  Jiri Bartek; Joanna M Merchut-Maya; Apolinar Maya-Mendoza; Olesja Fornara; Afsar Rahbar; Christian Beltoft Bröchner; Astrid Sehested; Cecilia Söderberg-Nauclér; Jiri Bartek; Jirina Bartkova
Journal:  Cell Cycle       Date:  2020-02-13       Impact factor: 4.534

Review 7.  Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma?

Authors:  Sylvia C Kurz; Patrick Y Wen
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

8.  Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection.

Authors:  Katelyn D Miller; Christine M Matullo; Katelynn A Milora; Riley M Williams; Kevin J O'Regan; Glenn F Rall
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

9.  The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

10.  A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.

Authors:  Julius W Kim; J Robert Kane; Wojciech K Panek; Jacob S Young; Aida Rashidi; Dou Yu; Deepak Kanojia; Tanwir Hasan; Jason Miska; Miguel A Gómez-Lim; Ilya V Ulasov; Irina V Balyasnikova; Atique U Ahmed; Derek A Wainwright; Maciej S Lesniak
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.